Letters, Testimony & Comments

April 13, 2011
Testimony of the Biotechnology Industry Organization (BIO) Hearing of the House Committee on Health, Education and Welfare April 13, 2011 Regarding Rhode Island House Bill 5629: "AN ACT AMENDING THE RHODE ISLAND FOOD, DRUGS, AND...
April 11, 2011
The Biotechnology Industry Organization ("BIO") is pleased to submit responses to question numbers 1,2, 4, 5, and 6 of the Senate Energy and Natural Resources Committee's March 21, 2011 Clean Energy Standard ("CES") White...
April 7, 2011
Re: Comments on Section 6002 of the Affordable Care Act Dear Sir or Madam: BIO appreciates the opportunity to comment on the implementation of the Physician Transparency and Reporting provisions enacted in 2010 as part of the Affordable Care...
April 7, 2011
Re: Docket No. FDA–2010–D–0643: Electronic Source Documentation in Clinical Investigations Dear Sir/Madam: The Biotechnology Industry Organization (BIO) thanks the Food and Drug Administration (FDA) for the opportunity to...
April 7, 2011
Hearing Testimony Scott Koenig, M.D., PH.D. Before the House of Representatives Committee on Small Business Good morning Chairman Graves, Ranking Member Velázquez, Members of the Committee, ladies and gentleman. I am President and...
April 4, 2011
E mail - ImprovingRegulations.SuggestionBox@epa.gov RE: Docket ID No. EPA-HQ-OA-2011-0157 (Improving Regulations: Pesticides) and EPA-HQ-OA-2011-0156 (Improving Regulations: General), 76 Fed.Reg. 9988 (February 23, 2011); To whom it may...
April 1, 2011
Re: Request for Comments on the Strategy for American Innovation Subject: Innovation Strategy RFI Email: competitiveness@doc.gov Dear Mr. Connor: The Biotechnology Industry Organization (BIO) appreciates the opportunity to respond to this...
March 24, 2011
On behalf of the Biotechnology Industry Organization (BIO) and its more than 1,100 member companies, academic institutions, state biotechnology centers and related organizations in all 50 states, I am writing to express our strong support for H.R...
March 24, 2011
March 24, 2011 As our economy begins to improve, job creation remains a critical priority toward ensuring a broad, deep and sustained recovery. To that end, legislation to strengthen our patent system will drive job growth by encouraging...
March 23, 2011
Statement Opposing S.B. 2276 The Biotechnology Industry Organization (BIO) respectfully submits the following statement in opposition to the universal vaccine purchase program set forth in Senate Bill 2276. While we recognize that the state is...
March 18, 2011
_________________ MICROSOFT CORPORATION, Petitioner, v. I4I LIMITED PARTNERSHIP AND INFRASTRUCTURES FOR INFORMATION, INC., Respondents. _________________ On Writ of Certiorari to the United States Court of Appeals for the Federal Circuit...
March 8, 2011
Re: Docket No. FDA-2009-N-0247-0260: FDA Transparency Initiative: Improving Transparency to Regulated Industry Dear Sir/Madam: The Biotechnology Industry Organization (BIO) thanks the Food and Drug Administration (FDA) for the opportunity to...
March 4, 2011
RE: Request for comments on Appendix 3 of the Chairperson’s Report on the November 15-16, 2010 Facilitated Work Session of the Codex Committee on Food Labeling on the topic of the Labeling of Foods and Food Ingredients Obtained through...
March 4, 2011
Re: Draft Environmental Assessment: Use of Genetically Modified, Glyphosate-Tolerant Soybeans and Corn on National Wildlife Refuge Lands in the Mountain-Prairie Region (Region 6) Dear Colleague: These comments are submitted by the...
March 4, 2011
Re: Draft 2012 Part D Call Letter Dear Administrator Berwick: The Biotechnology Industry Organization (BIO) appreciates this opportunity to comment on the Centers for Medicare & Medicaid Services’ (CMS) Draft 2012 Call Letter. BIO is...
March 2, 2011
Re: Docket No. FDA–2011–N–0002: Advisory Committee for Pharmaceutical Science and Clinical Pharmacology; Notice of Meeting Dear Sir/Madam: On behalf of the Biotechnology Industry Organization (BIO), thank you for the...
March 1, 2011
HHS-OS-2010-002: Request for Information Regarding Value-based Insurance Design in Connection with Preventive Care Benefits The Biotechnology Industry Organization (BIO) appreciates this opportunity to comment on the design aspects of preventive...
February 28, 2011
Comments of Biotechnology Industry Organization on EPA’s Draft Report Biofuels and the Environment: First Triennial Report to Congress EPA Docket # EPA-HQ-ORD-2010-1077 BIO is pleased to submit comments on EPA’s Draft Report...
February 25, 2011
Patent Amendment (Human Genes and Biological Materials) Bill 2010 Submission to the Senate Legal and Constitutional Affairs Legislation Committee by the Biotechnology Industry Organization February 25, 2011   About BIO/Introduction...